...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >SITE SELECTION FOR CLINICAL RESEARCH IN INDIA
【24h】

SITE SELECTION FOR CLINICAL RESEARCH IN INDIA

机译:印度临床研究的选址

获取原文

摘要

For biopharmaceutical companies, in order to prevent excessive expenditure, completing a clinical trial on time is a very important factor. Selection of the right study site(s), trained investigators and site coordination team are key factors in determining timely completion of the study. There are few criteria (study and sponsor specific) that have to be met by sites to allow them to qualify and participate in the study. By adhering to these, the value of the sponsor’s time and money can be enhanced. Though site selection in India is similar to that in other countries, there are a few cultural differences that the sponsors should be aware of. Based on our experiences, we provide guidance here to address practical issues that may be encountered while selecting a site and an investigator in India. Study sites in India have the potential to become world-class study sites, but require an infrastructure and proper training. With an available patient pool along with an unmet health need, Indian sites offer an attractive alternative to their foreign counterparts.
机译:对于生物制药公司而言,为了防止过度支出,按时完成临床试验是非常重要的因素。选择正确的研究地点,训练有素的研究人员和地点协调团队是确定及时完成研究的关键因素。站点必须满足的标准很少(研究和赞助者特定),以使他们有资格参与研究。坚持这些原则,可以提高赞助商时间和金钱的价值。尽管印度的选址与其他国家/地区类似,但赞助商应注意一些文化差异。根据我们的经验,我们在此提供指导,以解决在印度选择地点和研究人员时可能遇到的实际问题。印度的学习场所有可能成为世界一流的学习场所,但需要基础设施和适当的培训。由于有可用的患者库以及未满足的健康需求,印度站点可以提供比国外站点更有吸引力的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号